Immuneering Corporation (IMRX) Total Assets by Year
Immuneering Corporation closed fiscal year 2025 with $232.0M in total assets, $13.5M in total liabilities and $218.5M in shareholder equity. This represents an increase of 340.1% from the prior fiscal year. The table below carries 6 fiscal years, from 2020 to 2025, and the quarters Immuneering Corporation has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
IMRX Balance Sheet by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY2510-K | FY2410-K | FY2310-K | FY2210-K | FY2110-K | FY2010-K |
|---|---|---|---|---|---|---|
| Total Assets | $232.0M+340.1% | $52.7M-48.6% | $102.6M-16.2% | $122.4M-26.6% | $166.7M+333.9% | $38.4M |
| Total Liabilities | $13.5M+19.2% | $11.3M-5.7% | $12.0M-4.1% | $12.5M+16.7% | $10.7M-82.4% | $60.9M |
| Total Equity | $218.5M+427.9% | $41.4M-54.3% | $90.6M-17.5% | $109.9M-29.6% | $156.0M+793.8% | -$22.5M |
IMRX Balance Sheet by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K | Q3'2310-Q |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $202.1M+404.4% | $214.8M+323.8% | $232.0M+340.1% | $241.1M+251.6% | $40.1M-48.0% | $50.7M-42.4% | $52.7M-48.6% | $68.6M-39.8% | $77.1M-38.3% | $88.0M-18.3% | $102.6M-16.2% | $113.9M-14.8% |
| Total Liabilities | $11.3M+1.8% | $8.3M-6.2% | $13.5M+19.2% | $13.1M+20.7% | $11.1M+3.1% | $8.8M-4.6% | $11.3M-5.7% | $10.8M+9.9% | $10.8M+10.1% | $9.3M-6.5% | $12.0M-4.1% | $9.9M-16.4% |
| Total Equity | $190.7M+559.2% | $206.5M+393.6% | $218.5M+427.9% | $228.0M+295.0% | $28.9M-56.4% | $41.8M-46.8% | $41.4M-54.3% | $57.7M-44.5% | $66.3M-42.4% | $78.7M-19.5% | $90.6M-17.5% | $104.0M-14.7% |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More Immuneering Corporation financials
Frequently Asked Questions
What was Immuneering Corporation's total assets in fiscal year 2025?
Immuneering Corporation closed fiscal year 2025 with $232.0M in total assets, $13.5M in total liabilities and $218.5M in shareholder equity.
How fast is Immuneering Corporation's total assets growing?
Immuneering Corporation (IMRX) total assets rose by 340.1% year over year, from $52.7M to $232.0M in fiscal year 2025.
How has Immuneering Corporation's total assets changed over the years?
Across the 6 fiscal years this page covers, Immuneering Corporation (IMRX) total assets went from $38.4M in fiscal year 2020 to $232.0M in fiscal year 2025.
What was Immuneering Corporation's total assets in the most recent quarter?
Immuneering Corporation (IMRX) reported $202.1M in total assets in Q2 2026. This represents an increase of 404.4% from the same quarter a year earlier.
What does total assets mean on a financial statement?
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what Immuneering Corporation (IMRX) reported on that line in every period on record.